Dirk Daelemans

33PUBLICATIONS
101CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designBiologically active moleculesIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 24, 2026
Preclinical characterization of a reversible XPO1 inhibitor for cancer therapy.

|Aug 13, 2026
Synthesis of 1,3,5-Triazine-Indole Conjugates as Broad-Spectrum Coronavirus Entry Inhibitors.

|Nov 25, 2025
SINE compounds activate exportin 1 degradation through an allosteric mechanism.

Casey E Wing, Ho Yee Joyce Fung, Bert Kwanten

|Aug 04, 2025
Synthesis, Antiproliferative Activity, ADME Profiling, and Docking Studies of Novel 1, 2, 3-Triazole Derivatives of 2-Amino and 2-Mercaptobenzoxazole.

Robert Ostrički, Anja Rakas, Vesna Rastija

|May 07, 2025
A Sustainable Synthesis of Novel 2-(3,4-Disubstituted phenyl)benzoxazole Derivatives and Their Antiproliferative and Antibacterial Evaluation.

Anja Rakas, Leentje Persoons, Dirk Daelemans

|Nov 23, 2024
Ibetazol, a novel inhibitor of importin β1-mediated nuclear import.

Thomas Vercruysse, Els Vanstreels, Maarten Jacquemyn

Pageof 6

Frequent Collaborators

14 joint publications

Leentje Persoons

10 joint publications

Maarten Jacquemyn

6 joint publications

Yuh Min Chook

6 joint publications

Marijana Hranjec